Juno Therapeutics vs Kite Pharma

Juno Therapeutics vs Kite Pharma, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Juno Therapeutics is on 66/100 and Kite Pharma on 66/100.

Juno TherapeuticsBiotechnology company focused on developing cancer immunotherapies.
Kite Pharma logo
Kite PharmaBiotechnology company developing and commercializing cell therapies for cancer treatment.
Try Kite Pharma

Where each one leads

Juno Therapeutics

Leads on none of the measures we hold for both companies.

Kite Pharma

  • funding raised: $421M against $317M

At a glance

MeasureJuno TherapeuticsKite Pharma
What it isBiotechnology company focused on developing cancer immunotherapies.Biotechnology company developing and commercializing cell therapies for cancer treatment.
CategoryBiotechnology, Pharmaceuticals, Cancer Immunotherapy, CartBiotechnology, Pharmaceuticals, Oncology, Cell Therapy
Sells toBusiness modelB2BB2B
OfferingServicesServices
Founded20132009
HeadquartersSeattle, United StatesSanta Monica, United States
StatusActiveActive

Size, funding and growth

MeasureJuno TherapeuticsKite Pharma
Total funding$317M$421M
Latest roundSeries BVenture

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureJuno TherapeuticsKite Pharma
StartupHub scoreOur 0-100 rating66/10066/100
Traction40/10040/100
Team90/10080/100
Community15/100Not published
Search visibility15/10015/100
Quality87/10090/100
Agent readinessHow well an AI agent can read and act on the siteNot publishedF (35/100)
Domain ratingLink authority, 0-100Not published62/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureJuno TherapeuticsKite Pharma
CDNNot detectedCloudflare
FrameworksNot detectedTailwind CSS, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

Juno Therapeutics vs Kite Pharma: common questions

Which is better, Juno Therapeutics or Kite Pharma?

Both score the same on our 0-100 rating, so the choice comes down to the 14 data points in the tables above rather than overall company strength.

How do Juno Therapeutics and Kite Pharma compare on the numbers?

Kite Pharma leads on funding raised ($421M against $317M).

Read the full Juno Therapeutics review and pricing or the Kite Pharma review and pricing. You can also browse other Juno Therapeutics alternatives we track.